GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sumitomo Pharma Co Ltd (OTCPK:DNPUF) » Definitions » Price-to-Tangible-Book
中文

Sumitomo Pharma Co (Sumitomo Pharma Co) Price-to-Tangible-Book

: (As of Today)
View and export this data going back to 2009. Start your Free Trial

As of today (2024-04-24), Sumitomo Pharma Co's share price is $2.70. Sumitomo Pharma Co's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was $-3.69. Hence, Sumitomo Pharma Co's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for Sumitomo Pharma Co's Price-to-Tangible-Book or its related term are showing as below:

During the past 13 years, Sumitomo Pharma Co's highest Price to Tangible Book Ratio was 54.02. The lowest was 1.66. And the median was 3.58.

DNPUF's Price-to-Tangible-Book is not ranked *
in the Drug Manufacturers industry.
Industry Median: 2.31
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Sumitomo Pharma Co's share price is $2.70. Sumitomo Pharma Co's Book Value per Sharefor the quarter that ended in Dec. 2023 was $6.01. Hence, Sumitomo Pharma Co's P/B Ratio of today is 0.45.

Sumitomo Pharma Co Price-to-Tangible-Book Historical Data

The historical data trend for Sumitomo Pharma Co's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sumitomo Pharma Co Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.08 - 39.14 34.30 -

Sumitomo Pharma Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.00 - - - -
Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Sumitomo Pharma Co's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sumitomo Pharma Co Price-to-Tangible-Book Distribution

For the Drug Manufacturers industry and Healthcare sector, Sumitomo Pharma Co's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Sumitomo Pharma Co's Price-to-Tangible-Book falls into.


Sumitomo Pharma Co Price-to-Tangible-Book Calculation

Sumitomo Pharma Co's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Dec. 2023 )
=2.70/-3.693
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price to Tangible Book=Market Cap/Tangible Equity
=Market Cap/(Total Stockholders Equity-Preferred Stock-Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Sumitomo Pharma Co Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Sumitomo Pharma Co's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Sumitomo Pharma Co (Sumitomo Pharma Co) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sumitomo Pharma Co Ltd (OTCPK:DNPUF) » Definitions » Price-to-Tangible-Book
Comparable Companies
TSE:4540 TSE:4887 TSE:4547 TSE:4521 TSE:4534 TSE:4553 TSE:4569 TSE:4551 TSE:4559 TSE:4886 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 XSWX:SDZ VTRS NBIX
Traded in Other Exchanges
4506:Japan DPM:Germany
Address
6-8, Doshomachi 2-chome, Chuo-ku, Osaka, JPN, 541-0045
Website
https://www.sumitomo-pharma.com
Sumitomo Pharma Co Ltd is a specialty and generic drug manufacturing company. Sumitomo's vast majority of sales are generated in North America, followed by Japan. The company's core business is its pharmaceutical products business. The pharmaceutical business maintains a focus on a variety of areas, including cardiovascular/diabetes, psychiatry & neurology, and specialty areas. Sumitomo considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.